Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
about
Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinomaSimultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"Mechanisms of HIV-1 to escape from the host immune surveillance.Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell responseIdentification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expressionHLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the otherCD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice.Cytolytic T lymphocytes from HLA-B8+ donors frequently recognize the Hodgkin's lymphoma associated latent membrane protein 2 of Epstein Barr virus.Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cellsEpitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memoryCD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferationDecreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2.The B subunit of Escherichia coli heat-labile enterotoxin enhances CD8+ cytotoxic-T-lymphocyte killing of Epstein-Barr virus-infected cell lines.A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors.Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function.Mechanisms of interference with the MHC class I-restricted pathway of antigen presentation by herpesviruses.Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients.Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts.
P2860
Q24610485-9067DB3D-B4E9-4FE4-8952-CADACDDAA3F4Q24814428-CFD4F950-1606-46B4-BEDD-A89AD68CDC6CQ30327140-F1DFCEB1-A0A2-491D-B16A-E943C6F49F2AQ30442835-92D1F35A-E35B-40C7-B3CF-F703C1212BCDQ33783532-BFE58F50-81DC-4305-B9A1-F680BE6ED396Q33787144-865AC801-D931-4DF1-AA2A-BA47783F0CE1Q33804193-BD574A74-585C-4067-AED2-5F4E0D244F6BQ34150713-43373E4B-544F-4E0F-8B9D-1AD5327BB81CQ34712758-396D5D9B-04F7-4CF2-9047-DC6A8F48189EQ35621782-17DAA531-DD7F-4A4A-91B8-30B962DEE3BAQ35817394-02A99FAE-C94E-487F-9193-E2586C355D3BQ35857336-D03D5768-11DD-4CC7-B80F-0352092321A8Q36367550-4E4A2799-0E42-4349-9E39-B4B9FAFD55D7Q36399195-E887615B-4DAA-42A0-9A3F-669C4A6EAF9BQ36890569-39591AE2-7CD8-410A-9E4A-55BD4D74D942Q37145510-C1C2F0EC-81E7-43BF-9343-E0B38D477EFCQ37369220-3399720C-899A-40B1-B1D6-159216F21FE5Q39441043-8A34077F-5F4F-448D-AC61-872B5CE6A592Q39581864-BD4EFE2C-D0DC-479E-B086-F87EA1B99A96Q39700355-0616E156-864B-4739-90A2-EB5B2047A550Q39736862-BEE080A2-446D-441D-AD7B-36B97DA923A2Q39874070-4F7B1CCE-9950-4A0E-9156-2484CA3CA262Q40703241-793401A1-4E20-451D-8178-CDBF9A211968Q40723325-882DC2A0-BD6E-4861-9B41-C333B5B0B738Q41300816-AEB9CFD7-B588-40DE-A39C-B2EF6539464CQ54384017-A7FE79DA-BA75-4F8C-B66E-D71BF06058B3Q55259946-2450E06A-13EA-4E40-8D74-30CAAE23B5EF
P2860
Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Class I major histocompatibili ...... gainst which they were raised.
@en
type
label
Class I major histocompatibili ...... gainst which they were raised.
@en
prefLabel
Class I major histocompatibili ...... gainst which they were raised.
@en
P2093
P2860
P356
P1476
Class I major histocompatibili ...... gainst which they were raised.
@en
P2093
McMichael AJ
Rickinson AB
Signoret N
P2860
P304
P356
10.1084/JEM.181.6.2221
P407
P50
P577
1995-06-01T00:00:00Z